Sign in

CIK 0001077183

  • Large accelerated filer

NEOGENOMICS INC

Sign in to watch
Ticker
NEO
Exchange
Nasdaq
Industry
Services-Testing Laboratories
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
742897368
Phone
+1 239-768-0600
Business address
9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Former names
AMERICAN COMMUNICATIONS ENTERPRISES INC
  1. 4 Grant or award Director acquired 3,081 shares (grant or award)
  2. 4 Grant or award Director acquired 3,081 shares (grant or award)
  3. 4 Grant or award Director acquired 3,081 shares (grant or award)
  4. 4 Open-market sale President, Pharma Services sold 200,337 shares at an average $40.35 ($8,082,901)
  5. 4 Open-market sale President, Clinical Services sold 130,604 shares at $39.31 ($5,134,043)
  6. 4 Exercise or conversion Chief Medical Officer acquired 25,050 shares (option exercise)
  7. 4 Grant or award Chief Executive Officer acquired 55,736 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Strategy Officer acquired 4,655 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Chief Financial Officer acquired 6,207 shares (grant or award)
  12. 4 Grant or award Chairman and CEO acquired 56,423 shares (grant or award)
  13. 4 Grant or award President, Informatics acquired 4,345 shares (grant or award)
  14. 4 Grant or award VP and Chief Culture Officer acquired 1,862 shares (grant or award)
  15. 4 Grant or award General Counsel acquired 4,345 shares (grant or award)
  16. 4 Grant or award President, Clinical Services acquired 6,827 shares (grant or award)
  17. 4 Grant or award Chief Accounting Officer acquired 1,241 shares (grant or award)
  18. 4 Grant or award President, Pharma Services acquired 6,207 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 5,276 shares (grant or award)
  20. 4 Exercise or conversion Director acquired 117,286 shares (option exercise)

Page 13 of 30 · 589 filings